Yabao Pharmaceutical Group Co (SHSE:600351) Total Liabilities : ¥626 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Yabao Pharmaceutical Group Co Total Liabilities?

Yabao Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥626 Mil.

Yabao Pharmaceutical Group Co's quarterly Total Liabilities declined from Sep. 2024 (¥708.41 Mil) to Dec. 2024 (¥649.02 Mil) and declined from Dec. 2024 (¥649.02 Mil) to Mar. 2025 (¥625.67 Mil).

Yabao Pharmaceutical Group Co's annual Total Liabilities declined from Dec. 2022 (¥1,124.43 Mil) to Dec. 2023 (¥860.33 Mil) and declined from Dec. 2023 (¥860.33 Mil) to Dec. 2024 (¥649.02 Mil).

Yabao Pharmaceutical Group Co Total Liabilities Historical Data

The historical data trend for Yabao Pharmaceutical Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yabao Pharmaceutical Group Co Total Liabilities Chart

Yabao Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

1,209.39

1,113.10

1,124.43

860.33

649.02

Yabao Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															865.71	865.12	708.41	649.02	625.67

Yabao Pharmaceutical Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Yabao Pharmaceutical Group Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	582.015	+	(2.058	+	46.234
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	18.716)
	=	649

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	3543.943	-	2894.92
	=	649

Yabao Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	558.893	+	(1.88	+	46.18
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	18.716)
	=	626

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	3569.135	-	2943.466
	=	626

Yabao Pharmaceutical Group Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Yabao Pharmaceutical Group Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Yabao Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yabao Pharmaceutical Group Co Ltd (SHSE:600351) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602

Website

http://www.yabao.com.cn

Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.

Executives

Tang Ke	senior management
Zuo Zhe Feng	senior management
Xu Zhen Jiang	Supervisors
Wang Gang	senior management
Ren Peng Bo	Director
Ren Wei	senior management
Ning Hui Qiang	Supervisors
Ren Wu Xian	Director

Yabao Pharmaceutical Group Co Headlines

No Headlines